Translate

Wednesday, February 24, 2021

thumbnail

CYTX Cytori Therapeutics Inc gains 19% Feb 23, 2021

Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, including stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, urinary incontinence, and thermal burns combined with radiation injury. It also offers Celution System devices, proprietary enzymes, and sterile consumable sets to commercial customers, as well as for research customers developing new therapeutic applications for Cytori Cell Therapy in Europe, Japan, and other regions. In addition, the company provides StemSource devices, including a cryogenic freezer, measuring and monitoring equipment, and a database patient tracking system, as well as offers consulting, installation, and training services. Cytori Therapeutics, Inc. markets its products to hospitals, clinics, tissue banks, and stem cell banking companies through direct sales reps, distributors, and partners worldwide. The company was founded in 1996 and is headquartered in San Diego, California.http://www.priceseries.com/trade/CYTX-Cytori-Therapeutics-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2021020320210223.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive